Compare Hims and Hers Health Inc (HIMS) vs Sea Limited (SE) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

Sea Limited (SE) trades at $106.00, up 1.87% on the day, with a bearish technical signal despite bullish moving averages. The company reported strong revenue growth, with 2025 revenue reaching $22.94 billion and net income of $1.58 billion, though recent quarterly earnings have been mixed. Positive cash flow trends and a robust analyst consensus with a $131.00 price target highlight fundamental strength, but insider selling and competitive pressures present headwinds.

The outlook for SE is cautiously optimistic, driven by sustained revenue expansion and improving profitability. Key risks include execution challenges in its e-commerce and gaming segments, geopolitical tensions affecting operations, and insider selling activity. The stock's valuation multiples suggest growth expectations are priced in, requiring continued strong performance to justify further upside.